Key references: Nonsteroidal anti-inflammatory drugs in pain management

  • Bally M, Beauchamp ME, Abrahamowicz M, Nadeau L, Brophy JM. Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure. Pharmacoepidemiol Drug Saf 2018;27(1):69–77. https://www.ncbi.nlm.nih.gov/pubmed/29171096
  • Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E, et al. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ. 2017;357:j1909. https://www.ncbi.nlm.nih.gov/pubmed/28487435
  • Bally M, Nadeau L, Brophy JM. Studying additive interaction in a healthcare database: Case study of NSAIDs, cardiovascular profiles, and acute myocardial infarction. PLoS One. 2018;13(8):e0201884. https://www.ncbi.nlm.nih.gov/pubmed/30096158
  • Bhala N, Emberson J, Merhi A, Abramson S, Arber NCoxib and traditional Nsaid Trialists’ (CNT) Collaboration, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013;382(9894):769–79. https://www.ncbi.nlm.nih.gov/pubmed/23726390
  • Eccleston C, Cooper TE, Fisher E, Anderson B, Wilkinson NMR. Non‐steroidal anti‐inflammatory drugs (NSAIDs) for chronic non‐cancer pain in children and adolescents. Cochrane Database Syst Rev 2017;8:CD012537 https://www.ncbi.nlm.nih.gov/pubmed/28770976
  • Lee A, Cooper MG, Craig JC, Knight JF, Keneally JP. Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function. Cochrane Database Syst Rev 2007;(2):CD002765. https://www.ncbi.nlm.nih.gov/pubmed/17443518
  • Macintyre PE, Schug SA, Acute pain management: a practical guide. 4th Boca Raton, FL: CRC Press; 2014.
  • Martinez V, Beloeil H, Marret E, Fletcher D, Ravaud P, Trinquart L. Non-opioid analgesics in adults after major surgery: systematic review with network meta-analysis of randomized trials. Br J Anaesth 2017;118(1):22–31. https://www.ncbi.nlm.nih.gov/pubmed/28039239
  • Maund E, McDaid C, Rice S, Wright K, Jenkins B, Woolacott N. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related side-effects after major surgery: a systematic review. Br J Anaesth 2011;106(3):292–7. https://www.ncbi.nlm.nih.gov/pubmed/21285082
  • Michelet D, Andreu-Gallien J, Bensalah T, Hilly J, Wood C, Nivoche Y, et al. A meta-analysis of the use of nonsteroidal antiinflammatory drugs for pediatric postoperative pain. Anesth Analg 2012;114(2):393–406. https://www.ncbi.nlm.nih.gov/pubmed/22104069
  • Moore RA, Chi CC, Wiffen PJ, Derry S, Rice AS. Oral nonsteroidal anti-inflammatory drugs for neuropathic pain. Cochrane Database Syst Rev 2015(10):CD010902. https://www.ncbi.nlm.nih.gov/pubmed/26436601
  • Morales DR, Lipworth BJ, Guthrie B, Jackson C, Donnan PT, Santiago VH. Safety risks for aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX2 inhibitors: meta analysis of controlled clinical trials. J Allergy Clin Immunol 2014;134(1):40–45. https://www.ncbi.nlm.nih.gov/pubmed/24388008
  • Nissen SE, Yeomans ND, Solomon DH, Luscher TF, Libby P, Husni ME, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2016;375(26):2519–29. https://www.ncbi.nlm.nih.gov/pubmed/27959716
  • Schmidt M, Sørensen HT, Pedersen L. Diclofenac use and cardiovascular risks: series of nationwide cohort studies. BMJ. 2018;362:k3426. https://www.ncbi.nlm.nih.gov/pubmed/30181258
  • Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain 2019;160(1):53–9. https://www.ncbi.nlm.nih.gov/pubmed/30586071
  • Schug SA, Palmer GM, Scott DA, Halliwell R, Trinca JAPM:SE Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine, editors. Acute pain management: scientific evidence. 4th Melbourne: Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine; 2015. https://www.anzca.edu.au/safety-advocacy/advocacy/college-publications
  • Stehlik P, Rosella L, Henry D. Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs. Int J Epidemiol 2018;47(2):362–7. https://www.ncbi.nlm.nih.gov/pubmed/29390133
  • Stoltz RR, Harris SI, Kuss ME, LeComte D, Talwalker S, Dhadda S, et al. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects. Am J Gastroenterol 2002;97(1):65–71. https://www.ncbi.nlm.nih.gov/pubmed/11808971
  • Teerawattananon C, Tantayakom P, Suwanawiboon B, Katchamart W. Risk of perioperative bleeding related to highly selective cyclooxygenase-2 inhibitors: a systematic review and meta-analysis. Semin Arthritis Rheum 2017;46(4):520–8. https://www.ncbi.nlm.nih.gov/pubmed/27569276
  • Yuan JQ, Yang M, Threapleton DE, Qi XS, Ye DQ, Mao C, et al. Systematic review with meta-analysis: the gastrointestinal benefits of COX-2 selective inhibitors with concomitant use of low-dose aspirin. Aliment Pharmacol Ther 2016;44(8):785–95. https://www.ncbi.nlm.nih.gov/pubmed/27534608
  • Zhang J, Ding EL, Song Y. Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. JAMA 2006;296(13):1619–32. https://www.ncbi.nlm.nih.gov/pubmed/16968832